The Central Drugs Standard Control Organization (CDSCO) oversees medical devices in India, ensuring safety, efficacy, and quality. It regulates product approvals, clinical trials, and post-market surveillance to safeguard public health. CDSCO plays a pivotal role in harmonizing Indian regulations with international standards, fostering innovation while prioritizing patient safety and healthcare advancement nationwide. https://www.dueranconsultancy.com/medical-device-licenses

Japan Tuberculosis Treatment Market Overview: Demand, Drivers, and Challenges 2026–2032 The Japan Tuberculosis Treatment Market is poised for growth, with an estimated market size of USD 0.5122 billion in 2025, expanding at a CAGR of 5.65% to reach around USD 0.7121 billion by 2032. Factors driving this growth include increasing public health campaigns, innovative R&D initiatives, and a growing emphasis on timely diagnosis and treatment. https://www.thereportcubes.com/report-store/japan-tuberculosis-treatment-market